Blood test could replace colonoscopy for cancer screening?
NCT ID NCT07046585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test from Natera to see how well it can detect colorectal cancer and advanced growths in people at average risk. About 25,000 adults aged 40 and older who are already scheduled for a colonoscopy will give a blood sample. The results will be compared to what the colonoscopy finds to measure the test's accuracy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Natera, Inc
RECRUITINGAustin, Texas, 78753, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a registry make endoscopic procedures safer and more effective?
- A new clue in the fight against colorectal cancer recurrence?
- One simple score to rate colorectal cancer surgery quality?
- Engineered virus joins forces with immunotherapy to fight resistant cancers
- Massive 30-Year Women's health study reveals hidden disease links